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Implication for health policy/practice/research/medical education:
The study confirms the antibacterial activities of Terminalia catappa, Mangifera indica and Acalypha wilkesiana on the isolated 
S. aureus species. The several bioactive compounds contained in these plants extracts may serve as templates alternative medicine 
to treat infections caused by S. aureus.
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Introduction: Resistance of Staphylococcus aureus to available antibiotics is in alarming 
rate to put this into control with the use of natural products of plant derivatives. The aim of 
this research is centered on comparative study of plant extracts and antibiotics on S. aureus 
isolates from hospital patients.
Methods: A total of 106 human clinical samples were collected and analyzed for S. aureus isolates 
from urine, noses, ears and wounds of patients. The isolated S. aureus species were subjected 
to inhibition with plant extracts in comparison with commercial antibiotics. Twenty S. aureus 
isolates from the subjects’ samples were analyzed for multidrug resistance to antibiotics and 
plant leaves aqueous extracts. Out of these isolates, 9 were obtained from urine, 3 from noses, 
and 4 each from ears and wounds samples. These isolates were identified with code numbers
Results: The highest inhibition created on the isolates with modern medicine was between 11 
and 35 mm while for traditional medicine inhibition of the isolates was between 11 and 36 mm. 
Alkaloids and saponins were more than others in the plants extracts where value of alkaloids 
was between 2.42 and 3.63 and saponins between 2.60 and 3.27.
Conclusion: The plants extract inhibition was comparable to the antibacterial potency of 
commercial antibiotics on the tested bacteria species. The antibacterial activities observed 
from Terminalia catappa, Mangifera indica and Acalypha wilkesiana are probably due to several 
bioactive compounds contained in the plants and may serve as templates alternative medicine 
to treat infections caused by S. aureus.
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Introduction
Staphylococcus aureus is a world widely threatening 
bacteria pathogen. Its infections are very severe if not 
treated on time and will gradually progress to manifest 
certain disorders such as infections of the tissue, wounds, 
bone, joint and pneumonia (1). Treatment of S. aureus 
infections remain very challenging because in recent 
years Staphylococcus has been discovered to resist the 
popular antibiotics (tetracycline, methicillin, gentamicin 
[GEN], lincosamides and macrolides) used for treatment. 
Methicillin-resistant Staphylococcus aureus (MRSA) has 
been implicated as a serious problem in many medical 
institutions for its life-threatening situations (2). Also, the 
existence of mutated strains of MRSA is the vancomycin 
resistant S. aureus (VRSA) that has contributed additional 
problems to health care communities. The VRSA is at 
present the most threat of S. aureus strain to humans 
hence vancomycin has been misused for the treatment of 
Staphylococci infections (2).
Majority of data on prevalence of S. aureus in Africa 
are patient-based. Despite this, the ‘one health’ concept, 
including environmental persistence should be a vital 
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consideration for the effective control measure of this 
organism. Many studies in Nigeria have the information 
that in the hospital environment, infections due to S. 
aureus is the most prevalent (50%-80%) (3). In the 
neonatal intensive care units in Ghana, infections due to 
S. aureus accounts for 44% (4). S. aureus association on 
door handles and bathtubs in hospital environment in 
Benin implicated the Panton-Valentine leukocidin (PVL) 
as cause of nosocomial diseases (5).
The biological scientist communities have been attracted 
recently of the use of medicinal plants. The isolation and 
identification of effective secondary metabolites from 
these plants made them useful for herbal remedies. 
In health care system in Nigeria, diseases are treated 
with plants of medicinal values in conjunction with 
modern medicine. Folklore is believed to be based on 
holistic approach to good health, thus it perceives success 
and misfortune depending on the actions of individual 
and ancestral spirits on the balance or imbalance in the 
gap of the individual and social environment. This is 
however, in contrast to modern medicine that is based on 
technicality and analyses. 
The aim of this research is centered on phytochemical 
screening of plant extracts and comparative studies of 




A total of 106 human clinical samples were collected 
and analyzed for S. aureus isolation. The samples were 
collected from urine, wound, nose and ear of both male 
and female patients of different ages hospitalized in 
different wards of Ekiti State University Teaching Hospital 
(EKSUTH), the State specialist hospital, Ikere-Ekiti and 
General Hospital Iyin-Ekiti in Ekiti State Nigeria. From 
men, 33 urine samples, 14 ear swabs, 4 nose swabs and 7 
wound swabs were obtained. On the other hand, a total 
of 45 samples were obtained from women comprising 25 
urine samples, ten ear swabs 6 nose swabs and 7 wound 
swabs. 
Each urine sample was aseptically collected into a sterile 
sampling bottle, while ear, nose and wound swabs were 
collected using a sterile swab stick.
Plant Samples 
Fresh plant leaves of Terminalia catappa (Almond), 
Mangifera indica (Mango) and Acalypha wilkesiana 
(Acalypha) were obtained within the premises of Afe 
Babalola University and identified by Mr. Esimekhuai 
Donatus a botanist in the Department of Botany University 
of Ibadan Nigeria. Voucher specimens for T. catappa 
(UIH 22567), M. indica (UIH 22568) and A. wilkesiana 
(UIH 22569) were deposited at the herbarium of the 
Department of Botany, University of Ibadan, Nigeria. The 
leaves were brought to the laboratory, stripped from their 
stems, washed with distilled water and macerated into a 
fine infusion using a laboratory mechanical grinder. The 
solution was filtered with No. 1 Whatman filter paper 
and finally passed through membrane filter to obtain 
sterile extract. These were labeled and kept at 4°C in the 
refrigerator until use. 
Phytochemical screening
Qualitative analysis
To detect the presence of qualitative bioactive constituents 
from the plants extracts, standard chemical methods were 
employed with the criteria of Harborne (6) and Chethana 
et al (7). 
Quantitative screening
Quantitative phytochemical screening (flavonoids, 
tannins, saponins total phenol and alkaloids) from the 
plants extracts was done by the methods previously 
described by Harborne (6) and Chethana et al (7).
Antibiotic susceptibility test
Inoculums were prepared from saline suspension of 
isolates cultured for 18 to 24 hours. McFarland solution 
was used to adjust the solution to match the 0.5 standard of 
McFarland turbidity. With use of sterile swabs, inoculums 
were obtained from the adjusted suspensions which were 
allowed to drain properly before streaking onto freshly 
prepared Mueller-Hinton agar. The streaking was spread 
all over the surface of culture medium by rotating the 
plates at 60oC for even distribution of inoculums. The 
antibiotics disc was placed on the agar surface and pressed 
firmly with sterile forceps. The inoculated plates were 
left at room temperature for 15 minutes before they were 
incubated for 24-48 hours at 35oC. Effectiveness of the 
antibiotics was shown by clear zones around them which 
are measured and interpreted in accordance to the criteria 
of Clinical and Laboratory Standards Institute, as whether 
the pathogen is resistant, intermediate or sensitive (8).
Plants extract inhibitory test
The plants extracts were evaluated for antimicrobial 
potency by well-in-agar diffusion method. The surface of 
freshly prepared plates of Mueller-Hinton agar was spread 
plated with the bacterial inoculums and allowed to stand 
for 2 hours. Then, the wells of 6 mm were aseptically 
made with a sterile cork borer on the seeded agar plates. 
A volume of 50 µL from each extract solution was filled 
into the wells. The inoculated agar plates were incubated 
at 37oC for 24 to 48 hours. Clear inhibition zones after 
incubation were measured with a transparent ruler and 
interpreted as the degree of sensitivity.
Statistical analysis 
The statistical tool used for testing of hypothesis was 
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the analysis of variance (ANOVA). Data generated were 
expressed as mean ± standard error mean (SEM) and 
tested through one-way ANOVA or by students t test (8). 
P < 0.05 was considered significant.
Results
Susceptibility of isolates to antibiotics
Twenty S. aureus isolates from the subjects’ samples were 
analyzed for multidrug resistance to antibiotics and the 
plant leaves aqueous extracts. Out of these isolates, 9 were 
obtained from urine, 3 from noses, 4 each from ears and 
wounds of patients. These isolates were identified with 
code numbers Ui-Uiii and ESi-Esiii, respectively for urine 
and ear isolates. 
Twenty of S. aureus isolates from the clinical samples 
were all susceptible to ofloxacin (OFL) with zones of 
inhibition that ranged from 25 to 35 mm, followed by 
GEN with inhibition zone of between 16-23 mm and 
erythromycin (ERY) with zones between 11 and 25 mm. 
All the isolates were resistant to ceftazidime (CAZ) and 
cloxacillin (CXC). Nine of the isolates were sensitive to 
cefuroxime (CRX) with zones of inhibition ranged from 
10 to 25 mm. Eleven of the isolates were sensitive to CTR 
with inhibition zones between 11 and 20 mm. Meanwhile 
only one isolate was sensitive to augmentin (AUG) and 
was inhibited with a zone of 20 mm (Figure 1).
Susceptibility of isolates to plant extracts
The sensitivity pattern of the S. aureus isolates to leaves 
extract is represented in Figure 2. T. catappa exhibited 
the highest level of effectiveness against 18 isolates 
from urine, ear, nose and wounds with inhibition zones 
between 16 and 36 mm. Only 2 isolates were resistant to 
this plant extract. Nineteen isolates were inhibited with M. 
indica leaf extract with zones ranged from 11 to 32 mm 
inhibition. Fourteen out of the 20 isolates were resistant 
to the aqueous leaf extract of A. wilkesiana while 6 of the 
isolates were susceptible with inhibitory zones that ranged 
from 11 to 20 mm.
Phytochemical constituents
Table 1 presents the qualitative phytochemicals present 
in the leaves aqueous extracts of the plants. Tannin 
was more abundant in T. catappa than M. indica and 
A. wilkesiana. Phenol content was higher in T. catappa 
than others. Reducing sugars were present in all the leaf 
extracts. They were more in A. wilkesiana than other leaf 
extracts. Terpenoids were absent in T. catappa and M. 
indica but were more abundant in A. wilkesiana. Steroids 
and flavonoids were present in all plant extracts. Cardiac 
glycosides were present in both T. catappa and M. indica 
but totally absent in A. wilkesiana. Glycosides were 
abundantly present in T. catappa and A. wilkesiana but 
moderately present in M. indica.
 The quantity of tannins present in the plants extracts 
was 0.04±0.01, 0.06± 0.01 and 0.03± 0.01 for T. catappa, 
A. wilkesiana and M. indica, respectively. 
Flavonoids content was 0.17±0.03, 0.17±0.02 and 
0.00±0.00 in T. catappa, M. indica and A. wilkesiana 
respectively. No significant difference existed between 
the phenol quantities in T. catappa, (0.03±0.01), M. 
indica (0.00±0.03) and A. wilkesiana (0.04±0.02). Also, 
the quantity of saponins in T. catappa (2.60±0.02) was 
not significantly different from the values of M. indica 
(3.31±0.36) and A. wilkesiana (3.27±0.01). Alkaloids 
values from T. catappa, M. indica and A. wilkesiana were 
3.63±0.01, 2.42±0.60 and 3.52±0.01, respectively (Table 2).
Figure 1. Susceptibility pattern of Staphylococcus aureus to antibiotics.
MSW, male surgical ward; FSW, female surgical ward; MMW, male medical ward; FMW, female medical ward; SOP, surgical out patient; ENT, ear 
nose and throat, B, A, W (5, 4,1, 8, 3, 6, 10 respectively), Bed no.; ES= ear swab, NS, nose swab; WS, wound swab.
(ofloxacin, augmentin, ceftazidime, cefuroxime, gentamycin, ceftriaxone, erythromycin and cloxacillin).
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Discussion
The commercial antibiotics studied revealed that OFL was 
the most effective antibiotic on S. aureus isolates. This 
apparently level of susceptibility to OFL suggest that it 
could be a preferred drug for treating S. aureus infections 
in the area studied for this research, especially at the 
present time. This finding is consistent with previous 
reports (16; 17). However, low sensitivity was reported 
among most strains of MRSA isolated from patients with 
ocular infections (9).
S. aureus susceptibility to Gentamycin in present study 
compares favorably with reports published in the South-
western part of Nigeria (10). Gentamycin is supposed to be 
an alternative antibiotic for treating infections of MRSA. 
In the past years, CAZ has basically been prescribed for 
treating Staphylococcal infections because of dependable 
sensitivity results it presented in vitro. This was reported 
by Ndip et al. (11) with 78% and Amadi et al (12) who 
recorded sensitivity of 85.4%. Meanwhile, the susceptibility 
of S. aureus to cloxacillin (CXC) as observed in this study 
is in variance with the current trend. However, there is 
Figure 2. Inhibition of Staphylococcus aureus isolate with plants extracts.
Key: MSW= male surgical ward, FSW= female surgical ward, MMW=male medical ward, FMW= female medical ward, SOP= surgical 
out patient, ENT= ear nose and throat, B, A, W (5, 4, 1, 8, 3, 6, 10, respectively) = Bed no., ES= ear swab, NS=nose swab and WS= 
wound swab.
Table 1. Qualitative phytochemicals from the aqueous leaf extracts
Phytochemical 
constituents
T. catappa M. indica A. wilkesiana
Alkaloids ++ ++ ++
Tannin +++ ++ ++
Phenol +++ ++ ++
Saponin + + +
Terpenoids - - +++
Steroids +++ ++ +
Flavonoids +++ +++ +
Cardiac glycosides + + -
Reducing sugars ++ ++ +++
Glycosides + ++ +
+++: Abundantly present, ++: Moderately present, +: Present, -: Absent. 
no correlation with the reports of some other researchers 
(13) where they all observed low susceptibility response 
to CXC. The resistance in high-level could be associated 
with earlier exposure of these antibiotics to bacteria 
which may have developed resistance hence the level of 
antibiotic abuse is relatively high in this area of study. This 
could arise from self-medication, inadequate completion 
of prescribed drugs and inadequate prescription of drugs 
(14). Complete resistance of the S. aureus isolates to CAZ 
was observed. This could be due to over use of this drug 
by individuals and such could develop resistance to this 
drug overtime. However, this finding is contrasting to the 
observation of Dang-Thic et al (15) who reported total 
susceptibility with CAZ. Dang-Thic et al (15) stated that 
the current market has many products containing ceftiofur 
(a third-generation cephalosporin) as such pharmacists 
should be concerned about the development of resistance 
to this antibiotic in the near future. 
While 9 of the isolates were sensitive to CRX, only 
one was sensitive to AUG. The observed low resistance 
to CRX and AUG belonging to the fluoroquinolones, 
and the susceptibility of all isolated S. aureus species to 
OFL and GEN is in support of the previous findings by 
Oguzkaya-Artan et al (16). The profound activity of these 
agents on bacteria species may obviously be as a result 
of mode of inhibition which is principally bactericidal. 
The low resistance of isolated S. aureus to AUG could 
result from the presence of a compound (clavulanic 
acid) which is a competitive inhibitor of beta-lactamases. 
This compound restores the antimicrobial potency of 
beta-lactam antibiotics against S. aureus. S. aureus is a 
bacterium known for its ability to secret beta-lactamase. 
S. aureus infections can effectively be treated with CRX, a 
second-generation cephalosporin agent which has ability 
to resist beta-lactamases. These antibiotics which showed 
varied activities on the isolated S. aureus species could be 
as a statement of their expensiveness and therefore cannot 
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no correlation with the reports of some other researchers 
(13) where they all observed low susceptibility response 
to CXC. The resistance in high-level could be associated 
with earlier exposure of these antibiotics to bacteria 
which may have developed resistance hence the level of 
antibiotic abuse is relatively high in this area of study. This 
could arise from self-medication, inadequate completion 
of prescribed drugs and inadequate prescription of drugs 
(14). Complete resistance of the S. aureus isolates to CAZ 
was observed. This could be due to over use of this drug 
by individuals and such could develop resistance to this 
drug overtime. However, this finding is contrasting to the 
observation of Dang-Thic et al (15) who reported total 
susceptibility with CAZ. Dang-Thic et al (15) stated that 
the current market has many products containing ceftiofur 
(a third-generation cephalosporin) as such pharmacists 
should be concerned about the development of resistance 
to this antibiotic in the near future. 
While 9 of the isolates were sensitive to CRX, only 
one was sensitive to AUG. The observed low resistance 
to CRX a d AUG belonging to the fluor quinolones, 
and the susceptibility of all isolated S. a reus species to 
OFL and GEN is in support of the previous findings by 
Oguzkaya-Artan et al (16). The profound activity of these 
a ents on bacteria species may obviously be as a result 
of mode of inhibition which is principally bactericidal. 
The low res stance of isolated S. aureus to AUG could 
resu t from he presence of a compound (clavulanic 
acid) which is a comp titive inhibit r of beta-la t mases. 
This compound restores the antimicro ial potency of 
beta-lactam a tibiotics against S. aureus. S. aureus is a 
bacterium known for its ability to secret beta-lactamase. 
S. aureus infections can effectively be treated with CRX, a 
second-generation cephalosporin agent which has ability 
to resist beta-lactamases. These antibiotics which showed 
varied activities on the isolated S. aureus species could be 
as a statement of their expensiveness and therefore cannot 
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easily be misused. The availability of this antibiotic in 
injectable form which requires administration by experts 
is also a factor. 
The high susceptibility rate of the S. aureus isolates 
to ERY was contrasting to the findings of Onanuga et 
al who observed a moderately high resistance (17). The 
resistance effect could have occurred as a result of the 
drugs uncontrolled usage, due to selection pressure that 
favors the increase of resistant strains. 
It has been reported in surveys that almost all introduced 
antibiotics have encountered resistance by microorganisms 
(18). Outside that, some antibiotics have presented 
severe side effects on hosts, where depletion of beneficial 
gut and mucosal microorganisms, hypersensitivity, 
immunosuppression and allergic reactions are inclusive 
(19). The recorded inhibition effect with the employed 
standard reference antibiotic compares with the plants 
extract potency on the isolated S. aureus species. Aqueous 
extract of A. wilkesiana leaves demonstrated the same 
level of inhibition as AUG. Furthermore, this leaf extract 
expressed a greater rate of antimicrobial potency on S. 
aureus isolates compared to CAZ and CXC. However, 
Oluduro et al (20) reported that S. aureus and S. typhi 
developed resistance to amoxicillin. In their study, these 
bacteria species were inhibited with aqueous, ethanol and 
methanol leaf extracts. The highest antimicrobial activity 
was observed with T. catappa which was of better effect 
on 18 isolates with wider zones of inhibition than the 
commercial antibiotics used in this study. Also, aqueous 
leaf extract of M. indica demonstrated higher antimicrobial 
effect on 19 isolates than the antibiotics used except OFL 
from which a wider zone of inhibition was observed. 
This is an indication that the crude leaf extracts were as 
effective as the employed commercial antibiotics. The 
effectiveness of the plants extracts on the isolated S. aureus 
species confirms their use against S. aureus-mediated 
infections and also gastroenteritis and skin dermatitis. 
Since remarkable inhibition was observed on the isolated 
S. aureus species, the exhibited antibacterial activity might 
be of broad spectrum potential (20). 
All the S. aureus isolates from urine, ear and wound 
samples responded with very high levels of susceptibility 
to the aqueous extracts of T. catappa and M. indica 
leaves. However, 6 isolates (3 from urine and 3 from ear 
samples) showed susceptibility to A. wilkesiana. On the 
other hand, the aqueous leaf extract of A. wilkesiana was 
not effective against S. aureus isolates of nose and wound 
samples. A. wilkesiana Muell Arg extract among other 
Acalypha species, has been found useful for its medicinal 
value in treating malaria fever, fungal infections and 
gastrointestinal disorder (21), antihypertension properties 
(22) and for its antimicrobial activities (23). The reason 
for its non-inhibitory effect to S. aureus isolated from 
nose and wound samples are not clear. Also, neither A. 
wilkesiana nor T. catappa and M. indica inhibited S. aureus 
isolated from nose samples. The presence of terpenoids in 
the aqueous extract of A. wilkesiana leaves corresponds 
with the reports from previous studies by Oluduro et a. 
(20). A report by Awe and Eme (24) suggested that due 
to antibacterial activities of A. wilkesiana, in inhibition of 
both Gram positive bacteria species (S. aureus) and Gram 
negative bacteria species (Klebsiella pneumoniae, Shigella 
sp. and E. coli), it could be a broad spectrum antibacterial 
agent. The phytochemical compounds screened from 
the plant leaves determined their antibacterial potency. 
Meanwhile, some of chemicals such as flavonoids, 
saponins and tannins have been reported in several 
literatures as antibacterial agents. The qualitative and 
quantity phytochemicals screened from the leaves of A. 
wilkesiana showed the presence of useful antibacterial 
plant chemicals (flavonoid, saponin, reducing sugars, 
terpenoids and tannin) in varying proportions and also 
with traces of glycosides and steroids. These could be 
attributed to the antimicrobial activities observed with 
this plant extract. 
The phytochemical screening showed the presence 
of some bioactive components of alkaloids, tannin, 
saponin, steroids, cardiac glycosides, flavonoids, reducing 
sugars, glycosides, triterpenoids and phenol in all plant 
extracts. Antimicrobial activities have been displayed 
by many plants with high contents of phenols and 
alkaloids compounds. The quantities of saponin present 
in the aqueous extract of the 3 leaves extracts were not 
statistically significant. 
The high susceptibility of isolates to the aqueous extract 
of M. indica leaves may be attributed to the bioactive 
constituents present in this plant. These compounds 
contained in M. indica could be a good source of potential 
bioactive compounds for the treatment of infectious 
diseases such as pneumonia as reported by Ncube et al 
(25). M. indica leaf extract has antibacterial affinity against 
E. coli and other bacteria species under Enterobacteriaceae 
family. In the report of Khan et al. (26), the potential 
pharmacology associated with mangiferin inclusive of 
Table 2. Quantitative phytochemicals from the aqueous leaf extract
Samples Tannin Flavonoids Phenol Saponin Alkaloids
T. catappa 0.38±0.87a 0.17±0.03 a 0.03±0.06 2.60±0.02 3.63±0.87a
M. indica 0.28±0.05b 0.17±0.02 a 0.33±0.03 3.31±0.36 2.42±0.60
A. wilkesiana 0.56±0.07a 0.00±0.00 0.04±0.02 3.27±0.87 3.52±0.87b
S. V. (α = 0.05) (P = 0.02) 0.00 0.87 0.96 0.89
Values are mean ± standard deviations of triplicate determinations. Values with different superscripts per column are significantly different.
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its antimicrobial and antioxidant activities has been 
identified. Also, its in vitro effect on type II 5α-reductase, 
gastroprotective and antidiabetic effect in rodents have 
been reported (26). From results obtained in this study, it 
can be deduced that aqueous extract of T. catappa leaves 
is one of the very best sources of treatment for infections 
as extract of this plant leaves demonstrated the highest 
level of microbial inhibition against all S. aureus species 
isolated from patient’s urine, ear, wound and nose samples. 
This finding supports the reports of other researchers 
who used different solvents in the extraction of the plant 
leaves. T. catappa leaves are rich in tannin flavonoids, 
alkaloids and steroids. These components are able to 
inhibit certain phenotypic expression of quorum sensing 
(QS) in some test strains (27). In a study of antibacterial 
activity of T. catappa aqueous leaves extract in different 
stages extracted with water against various harmful 
microorganisms, the results showed that T. catappa leaves 
had the capacity of inhibiting various bacterial species 
including S. aureus (28). Pawar and Pal (29) in a study 
indicated that chloroform and methanol extracts exhibited 
valuable antimicrobial potency on gram-positive and 
gram-negative bacteria. The chloroform root extract of T. 
catappa showed antimicrobial activity against Escherichia 
coli and S. aureus while petroleum root ether extract of 
T. catappa was devoid of antimicrobial activity. However, 
the high susceptibility rate of S. aureus to this extract may 
be attributed to the numerous phytochemicals present in 
the plant.
Modern science and technology have achieved 
success in drug discovery development. Not with 
standing, microorganisms in alarming frequency still 
create resistant pattern to some of the available modern 
medicines. Chikere et al (30), in a study have reported that 
the extensive use of broad-spectrum antibiotics has led to 
the wide spread occurrence of nosocomial infections by 
multi drug resistant microorganisms. To this extent, the 
high numbers of S. aureus isolated from patients and their 
resistance structure to majority of the employed modern 
drugs ascertained the urgency in attention needed to save 
the world from multi drug resistant microbes by finding 
alternative effective measures for their eradication. Despite 
this, the ineffectiveness of some modern medicines is 
not discriminated as faced on traditional folklores. The 
continuous use of these ineffective antibiotics however, 
may favor the emergence of resistant strains of hospital 
and community acquired pathogens.
Conclusion
Staphylococcus aureus is a human threatening bacterium 
that can cause many illnesses in man and animals. OFL, 
GEN and ERY as recommended first line antibiotics in the 
management of S. aureus infections were not as effective 
on the isolated S. aureus as does by plants extracts. Since 
T. catappa, M. indica and A. wilkesiana contain several 
bioactive compounds based on their effective antibacterial 
potencies, they may serve as sources for novel antibiotics 
for the treatment of diseases.
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